⁦HFSA⁩ 2023 ⁦Farah Abdulhai⁩ ⁦@SaeidMirzaiDO⁩ ⁦Cleveland Clinic⁩ ⁦Samir Kapadia⁩ ⁦Lars Svensson⁩ ⁦Emily Littlejohn⁩ Autoimmune disorders and heart failure #cardiorheum

#RCM-Vol. 24 No. 11 🚵‍♂️Review Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments 📝by @SaeidMirzaiDO, Parag Chevli MD MS, Rishi Rikhi, MD🌱MS, Michael D. Shapiro #Familial_Hypercholesterolemia #CVD #lipoprotein #cholesterol #atherosclerosis 📢 imrpress.com/journal/RCM/24…

Excited to share our recent article published by first author/my peer mentor for life @SaeidMirzaiDO and superstar Kunaal Sarnaik. protect-us.mimecast.com/s/FlkeCzp5LgH8… W. H. Wilson Tang, MD Jerry Estep Cleveland Clinic IM Richard M. Wardrop III, MD, PhD, MACP, SFHM, FAAP JAHA American Heart Association

Happy to see our recent study in JAHA! Grateful for our team and the mentorship of W. H. Wilson Tang, MD. Kunaal Sarnaik Ian Persits, DO, MS Pieter Martens Jerry Estep

doi.org/10.1016/j.amjc… Excited to share our latest publication showing adverse short-term outcomes in TAVR recipients with low muscle mass W. H. Wilson Tang, MD @SaeidMirzaiDO Kunaal Sarnaik Serge C. Harb Samir Kapadia Grant Reed Cleveland Clinic IM Richard M. Wardrop III, MD, PhD, MACP, SFHM, FAAP

🚨Latest #FreeRead in JICE Preimplant Myopenia and Clinical Outcomes Among Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy 📖🧐rdcu.be/dA8p2 by @SaeidMirzaiDO, Maximilian C. Volk, Ian Persits, DO, MS, Kunaal S. Sarnaik, @_LAM_PHD, Po-Hao Chen,

Got to present our findings on outcomes of heart failure in SLE patients under the guidance and mentorship of heba wassif @SaeidMirzaiDO @cardioreumatology with two very special guest appearances Christopher Kanaan, MD Cleveland Clinic IM

Awesome time at ACC in Atlanta. Special thanks to W. H. Wilson Tang, MD @SaeidMirzaiDO Kunaal Sarnaik and Maximillian C. Volk (my curricular chief successor) #ACC2024 Richard M. Wardrop III, MD, PhD, MACP, SFHM, FAAP Cleveland Clinic IM heba wassif Andrew Higgins Penelope Rampersad MD, MSc, FRCPC, FACC Ran Lee, MD, FACC

@SaeidMirzaiDO, Michael D. Shapiro, et al. show intensive BP control in older adults with #Sarcopenia & #Hypertension nearly halved CVD risk without increasing adverse event... W. H. Wilson Tang, MD Salvatore Carbone, PhD, RDN, FHFSA, FASPEN @msingletonep Parag Chevli MD MS Rishi Rikhi, MD🌱MS @kazibwe_MD ahajrnls.org/4fBX4ES

🔴How do we maximize diuresis in #ADHF ? #OpenAccess #2023Review 🔹ccjm.org/content/89/10/… #cardiotwiteros #medtwitter #meded #medical #CardioEd #CardioTwitter #cardiology #paramedic #ekg #medicine

In this paper, we examined the hotly debated impact of statins on cognitive health. 🧠📊 The ongoing trials, PREVENTABLE & STAREE, may help clear some of the controversies. #Statins #Cognition #CVD_Prevention. link.springer.com/article/10.100…

❤️‍🩹 Diuresis in heart failure ccjm.org/content/89/10/…

Pleased to share our work highlighting the impact of body composition parameters in #CardiacAmyloid in the #EJHF! Thankful to W. H. Wilson Tang, MD for his mentorship, to my co-author Saeid Mirzai, and for the efforts of all involved. Teamwork makes research fun. European Society of Cardiology Journals

Check out our two reviews on Lp(a) as a causal risk factor for CVD and clinical trials for treating Lp(a)! Saeid Mirzai Michael D. Shapiro Nathan Wong link.springer.com/article/10.100… link.springer.com/article/10.100…

We would like to highlight work conducted by researchers from Cleveland Clinic Wake Forest University School of Medicine & Case Western Reserve. They used DAFS to quantify multi-region adipose tissue depots and LS (liver-spleen) ratio in patients undergoing cardiac resynchronization therapy. Voronoi Health Analytics

Refining cardiovascular risk assessment: The interplay of Lp(a) and waist-to-hip ratio 💫 Read the Editorial I had the honor to write w/ Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 doi.org/10.1016/j.pcad… 🔗Article Progress in Cardiovascular Diseases doi.org/10.1016/j.pcad… Michael D. Shapiro Khurram Nasir Roger Blumenthal Leandro Slipczuk

🚨 Great work from our Cardio-Rheumatology Center: Over 22 years, CV mortality in IMID patients fell but women still faced ~50% higher risk. Farah Abdulhai Osamah Badwan Rochell Issa (she/her) Tess Calcagno MD, PharmD Saeid Mirzai Jacqueline Tamis-Holland heba wassif Cleveland Clinic Heart, Vascular & Thoracic Cleveland Clinic IM Circulation

Grateful to Dr. Peters for his mentorship and guidance on our comprehensive review of exercise interventions in HFpEF, evaluating various training modalities and their impact on patient outcomes. link.springer.com/article/10.100…

Our recent study from SPRINT shows atherogenic dyslipidemia (low HDL + high TG) raises CVD risk, even with intensive BP control. Early detection in hypertension is key. doi.org/10.1016/j.pcad… #CardioTwitter #Hypertension

Excited to share our TTVR outcomes paper, now in press Structural Heart ✅ Low in-hospital ☠️, high procedural success, improvement in QoL 🔹 EVOQUE: lower 30-day mortality vs other THVs, but higher PPM rate 🔌⚡️ Grateful for the mentorship of Dr Samir Kapadia! structuralheartjournal.org/article/S2474-…